Evaluation of Neuropsychiatric outcomes in patients hospitalized with COVID-19 in a nationwide Veterans Health Administration cohort.

Hospitalized patients with COVID-19 have an increased risk of developing psychiatric symptoms associated with post-COVID-19 syndrome. We aimed to evaluate the impact of COVID-19 hospitalization on neuropsychiatric healthcare utilization as well as new-onset depression and dementia. This nationwide, retrospective, observational cohort study included hospitalized COVID-19 patients aged 18 years or older across the Veterans Health Administration database from January 1st, 2020 through January 1st, 2022.

CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).

Background And Objectives: Sodium-glucose cotransporter type 2 inhibitors have evolved into a novel drug class utilized for reductions in cardiovascular risk and heart failure hospitalization. We aimed to describe the impact of sodium-glucose cotransporter type 2 inhibitors on diuretic prescribing patterns and intermediate laboratory outcomes in patients with and without diuretic use.

Methods: This retrospective cohort study included patients taking empagliflozin as of 1 July, 2021.

A Retrospective Comparison of Intravenous Opioid Use for Abdominal Pain in the Emergency Department After Implementation of Order Set Restriction.

Background: This study was developed to provide insight into the effects of an i.v. opioid order set on prescribing of i.